Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
Eur Respir J, 59 (4) 2200166; 10.1183/13993003.00166-2022 |    |
CPAnet: the challenges of gaining evidence-based knowledge in chronic pulmonary aspergillosis
Rosanne Sprute, Helmut J.F. Salzer, Danila Seidel
Eur Respir J, 59 (4) 2102879; 10.1183/13993003.02879-2021 | |
Targeted therapy for pulmonary alveolar proteinosis: the time is now
Francesco Bonella, Raphael Borie
Eur Respir J, 59 (4) 2102971; 10.1183/13993003.02971-2021 | |
Proteinases in the pathogenesis of lymphangioleiomyomatosis lung disease: nibbling or chewing up the lung?
Yael Aschner, Gregory P. Downey
Eur Respir J, 59 (4) 2200405; 10.1183/13993003.00405-2022 | |
The paradox of immunosuppressants and COVID-19
Guang-Shing Cheng, Scott E. Evans
Eur Respir J, 59 (4) 2102828; 10.1183/13993003.02828-2021 | |
Can CPAP protect from cancer incidence in obstructive sleep apnoea patients? No evidence yet
Francesco Gambino, Maria R. Bonsignore
Eur Respir J, 59 (4) 2102742; 10.1183/13993003.02742-2021 | |
The last-minute redemption of inflammatory cells in lung repair
Paula Martín-Vicente, Cecilia López-Martínez, Guillermo M. Albaiceta
Eur Respir J, 59 (4) 2103000; 10.1183/13993003.03000-2021 | |
Some forgotten issues in sleep apnoea
Miguel Ángel Martínez-García, Patrick Lévy
Eur Respir J, 59 (4) 2101627; 10.1183/13993003.01627-2021 | |
ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure
Simon Oczkowski, Begüm Ergan, Lieuwe Bos, Michelle Chatwin, Miguel Ferrer, Cesare Gregoretti, Leo Heunks, Jean-Pierre Frat, Federico Longhini, Stefano Nava, Paolo Navalesi, Aylin Ozsancak Ugurlu, Lara Pisani, Teresa Renda, Arnaud W. Thille, João Carlos Winck, Wolfram Windisch, Thomy Tonia, Jeanette Boyd, Giovanni Sotgiu, Raffaele Scala
Eur Respir J, 59 (4) 2101574; 10.1183/13993003.01574-2021 | |
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma
John Busby, John G. Matthews, Rekha Chaudhuri, Ian D. Pavord, Timothy C. Hardman, Joseph R. Arron, Peter Bradding, Christopher E. Brightling, David F. Choy, Douglas C. Cowan, Ratko Djukanovic, Catherine E. Hanratty, Tim W. Harrison, Cecile T. Holweg, Peter H. Howarth, Stephen J. Fowler, James L. Lordan, Adel H. Mansur, Andrew Menzies-Gow, Robert M. Niven, Douglas S. Robinson, Samantha M. Walker, Ashley Woodcock, Liam G. Heaney
Eur Respir J, 59 (4) 2100768; 10.1183/13993003.00768-2021 | |
A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Ritesh Agarwal, Valliappan Muthu, Inderpaul Singh Sehgal, Sahajal Dhooria, Kuruswamy Thurai Prasad, Mandeep Garg, Ashutosh Nath Aggarwal, Arunaloke Chakrabarti
Eur Respir J, 59 (4) 2101787; 10.1183/13993003.01787-2021 | |
Ex vivo delivery of regulatory T-cells for control of alloimmune priming in the donor lung
Ei Miyamoto, Akihiro Takahagi, Akihiro Ohsumi, Tereza Martinu, David Hwang, Kristen M. Boonstra, Betty Joe, Juan Mauricio Umana, Ke F. Bei, Daniel Vosoughi, Mingyao Liu, Marcelo Cypel, Shaf Keshavjee, Stephen C. Juvet
Eur Respir J, 59 (4) 2100798; 10.1183/13993003.00798-2021 | |
A systematic review of blood biomarkers with individual participant data meta-analysis of matrix metalloproteinase-7 in idiopathic pulmonary fibrosis
Fasihul A. Khan, Iain Stewart, Gauri Saini, Karen A. Robinson, R. Gisli Jenkins
Eur Respir J, 59 (4) 2101612; 10.1183/13993003.01612-2021 | |
Methionine supplementation for multi-organ dysfunction in MetRS-related pulmonary alveolar proteinosis
Alice Hadchouel, David Drummond, Clément Pontoizeau, Laura Aoust, Maria-Margarita Hurtado Nedelec, Jamel El Benna, Elsa Gachelin, Caroline Perisson, Clémentine Vigier, Manuel Schiff, Florence Lacaille, Thierry Jo Molina, Laureline Berteloot, Sylvain Renolleau, Chris Ottolenghi, Jean-Marc Tréluyer, Jacques de Blic, Christophe Delacourt
Eur Respir J, 59 (4) 2101554; 10.1183/13993003.01554-2021 | |
Protease activity sensors enable real-time treatment response monitoring in lymphangioleiomyomatosis
Jesse D. Kirkpatrick, Ava P. Soleimany, Jaideep S. Dudani, Heng-Jia Liu, Hilaire C. Lam, Carmen Priolo, Elizabeth P. Henske, Sangeeta N. Bhatia
Eur Respir J, 59 (4) 2100664; 10.1183/13993003.00664-2021 | |
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study
Akshay N. Gupte, Pavan Kumar, Mariana Araújo-Pereira, Vandana Kulkarni, Mandar Paradkar, Neeta Pradhan, Pradeep Menon, Chandrasekaran Padmapriyadarsini, Luke-Elizabeth Hanna, Shri Vijay Bala Yogendra Shivakumar, Neesha Rockwood, Elsa Du Bruyn, Rajesh Karyakarte, Sanjay Gaikwad, Robert Bollinger, Jonathan Golub, Nikhil Gupte, Vijay Viswanathan, Robert J. Wilkinson, Vidya Mave, Subash Babu, Hardy Kornfeld, Bruno B. Andrade, Amita Gupta
Eur Respir J, 59 (4) 2100905; 10.1183/13993003.00905-2021 | |
The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection
Daniel Ward, Sanne Gørtz, Martin Thomson Ernst, Nynne Nyboe Andersen, Susanne K. Kjær, Jesper Hallas, Steffen Christensen, Christian Fynbo Christiansen, Simone Bastrup Israelsen, Thomas Benfield, Anton Pottegård, Tine Jess
Eur Respir J, 59 (4) 2100769; 10.1183/13993003.00769-2021 | |
Mycoplasma pneumoniae carriage evades induction of protective mucosal antibodies
Ruben Cornelis Anthonie de Groot, Silvia Cristina Estevão, Patrick Michael Meyer Sauteur, Aditya Perkasa, Theo Hoogenboezem, Emiel Benny Margriet Spuesens, Lilly Maria Verhagen, Anna Maria Christiane van Rossum, Wendy Wilhelmina Josephina Unger
Eur Respir J, 59 (4) 2100129; 10.1183/13993003.00129-2021 | |
Prediction of ventilator-associated pneumonia outcomes according to the early microbiological response: a retrospective observational study
Adrian Ceccato, Cristina Dominedò, Miquel Ferrer, Ignacio Martin-Loeches, Enric Barbeta, Albert Gabarrús, Catia Cillóniz, Otavio T. Ranzani, Gennaro De Pascale, Stefano Nogas, Pierluigi Di Giannatale, Massimo Antonelli, Antoni Torres
Eur Respir J, 59 (4) 2100620; 10.1183/13993003.00620-2021 | |
Prognostic factors for development of acute respiratory distress syndrome following traumatic injury: a systematic review and meta-analysis
Alexandre Tran, Shannon M. Fernando, Laurent J. Brochard, Eddy Fan, Kenji Inaba, Niall D. Ferguson, Carolyn S. Calfee, Karen E.A. Burns, Daniel Brodie, Victoria A. McCredie, Dennis Y. Kim, Kwadwo Kyeremanteng, Jacinthe Lampron, Arthur S. Slutsky, Alain Combes, Bram Rochwerg
Eur Respir J, 59 (4) 2100857; 10.1183/13993003.00857-2021 | |
The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD
Dave Singh, Jutta Beier, Carol Astbury, Maria G. Belvisi, Carla A. Da Silva, Alexandra Jauhiainen, Eulalia Jimenez, Alejhandra Lei, Sofia Necander, Jaclyn A. Smith, Ulrika Wählby Hamrén, Wenjing Xin, Ioannis Psallidas
Eur Respir J, 59 (4) 2100972; 10.1183/13993003.00972-2021 | |
Cancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy
Grégoire Justeau, Sebastien Bailly, Chloé Gervès-Pinquié, Wojciech Trzepizur, Nicole Meslier, François Goupil, Thierry Pigeanne, Sandrine Launois, Laurene Leclair-Visonneau, Philippe Masson, Acya Bizieux-Thaminy, Jean-Louis Racineux, David Gozal, Frédéric Gagnadoux
Eur Respir J, 59 (4) 2101935; 10.1183/13993003.01935-2021 | |
Maternal diet in pregnancy and child's respiratory outcomes: an individual participant data meta-analysis of 18?000 children
Sara M. Mensink-Bout, Evelien R. van Meel, Johan C. de Jongste, Isabella Annesi-Maesano, Adrien M. Aubert, Jonathan Y. Bernard, Ling-Wei Chen, Cyrus Cooper, Sarah R. Crozier, Wojciech Hanke, Nicholas C. Harvey, James R. Hébert, Barbara Heude, Joanna Jerzynska, Cecily C. Kelleher, John Mehegan, Fionnuala M. McAuliffe, Catherine M. Phillips, Kinga Polanska, Caroline L. Relton, Nitin Shivappa, Matthew Suderman, Vincent W.V. Jaddoe, Liesbeth Duijts
Eur Respir J, 59 (4) 2101315; 10.1183/13993003.01315-2021 | |
The antimicrobial peptide S100A8/A9 produced by airway epithelium functions as a potent and direct regulator of macrophage phenotype and function
Wioletta Skronska-Wasek, Sibel Durlanik, Huy Quang Le, Victoria Schroeder, Kerstin Kitt, James Peter Garnett, Stefan Pflanz
Eur Respir J, 59 (4) 2002732; 10.1183/13993003.02732-2020 | |
VEGF-C/VEGFR-3 signalling in macrophages ameliorates acute lung injury
Masahiro Yamashita, Miyuki Niisato, Yasushi Kawasaki, Sinem Karaman, Marius R. Robciuc, Yuji Shibata, Yoji Ishida, Ryosuke Nishio, Tomoyuki Masuda, Tamotsu Sugai, Masao Ono, Rubin M. Tuder, Kari Alitalo, Kohei Yamauchi
Eur Respir J, 59 (4) 2100880; 10.1183/13993003.00880-2021 | |
Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice
Marija Gredic, Cheng-Yu Wu, Stefan Hadzic, Oleg Pak, Rajkumar Savai, Baktybek Kojonazarov, Siddartha Doswada, Astrid Weiss, Andreas Weigert, Andreas Guenther, Ralf P. Brandes, Ralph T. Schermuly, Friedrich Grimminger, Werner Seeger, Natascha Sommer, Simone Kraut, Norbert Weissmann
Eur Respir J, 59 (4) 2101153; 10.1183/13993003.01153-2021 | |
Sleep apnoea in the elderly: a great challenge for the future
Ricardo S. Osorio, Miguel Ángel Martínez-García, David M. Rapoport
Eur Respir J, 59 (4) 2101649; 10.1183/13993003.01649-2021 | |
Spirometry forced expiratory time is driven by airflow limitation in asthmatic children
Jessica Taytard, Marc Koskas, Nicole Beydon
Eur Respir J, 59 (4) 2102620; 10.1183/13993003.02620-2021 | |
Epigenetic age acceleration in obstructive sleep apnoea is reversible with adherent treatment
Rene Cortese, David Sanz-Rubio, Leila Kheirandish-Gozal, José Maria Marin, David Gozal
Eur Respir J, 59 (4) 2103042; 10.1183/13993003.03042-2021 | |
Temporal progression of mediastinal lymphadenopathy in idiopathic pulmonary fibrosis
Tim J.M. Wallis, Eyjólfur Gudmundsson, Katarina Pontoppidan, Nesrin Mogulkoc, Recep Savas, Ömer Selim Unat, Katharine Vedwan, Sobana Battison, Fiona J. Thompson, Christopher J. Brereton, Ben G. Marshall, Sophie V. Fletcher, Luca Richeldi, Joseph Jacob, Mark G. Jones
Eur Respir J, 59 (4) 2200024; 10.1183/13993003.00024-2022 | |
Practices of therapeutic drug monitoring in tuberculosis: an international survey
Ioana Margineanu, Onno Akkerman, Dario Cattaneo, Delia Goletti, Deborah J.E. Marriott, Giovanni Battista Migliori, Fuad Mirzayev, Charles A. Peloquin, Ymkje Stienstra, Jan-Willem Alffenaar
Eur Respir J, 59 (4) 2102787; 10.1183/13993003.02787-2021 | |
Addition of bacterial filter alters positive airway pressure and non-invasive ventilation performances
Claudio Rabec, Emeline Fresnel, Yann Rétory, Kaixian Zhu, Karima Joly, Adrien Kerfourn, Benjamin Dudoignon, Alexis Mendoza, Antoine Cuvelier, Jean-François Muir, Boris Melloni, Jean-François Chabot, Jésus Gonzalez-Bermejo, Maxime Patout
Eur Respir J, 59 (4) 2102636; 10.1183/13993003.02636-2021 | |
The optimal arterial oxygenation range in critical care
Lingzhong Meng, Xu Zhao, Eddy Fan
Eur Respir J, 59 (4) 2102596; 10.1183/13993003.02596-2021 | |
Pulse oximeter measurements vary across ethnic groups: an observational study in patients with COVID-19
Colin J. Crooks, Joe West, Joanne R. Morling, Mark Simmonds, Irene Juurlink, Steve Briggs, Simon Cruickshank, Susan Hammond-Pears, Dominick Shaw, Timothy R. Card, Andrew W. Fogarty
Eur Respir J, 59 (4) 2103246; 10.1183/13993003.03246-2021 | |
War in Ukraine: an immense threat to the fight against tuberculosis
Victor Dahl, Giovanni Battista Migliori, Christoph Lange, Christian Wejse
Eur Respir J, 59 (4) 2200493; 10.1183/13993003.00493-2022 | |
Correlation of total serum HDL particles with a predictor of mortality risk in idiopathic pulmonary fibrosis
Taro Yasuma, Corina N. D'Alessandro-Gabazza, Hajime Fujimoto, Tetsu Kobayashi, Esteban C. Gabazza
Eur Respir J, 59 (4) 2103175; 10.1183/13993003.03175-2021 | |
Reply: Not all HDL particles are equal in idiopathic pulmonary fibrosis
Amisha V. Barochia, Scott D. Barnett, Nargues Weir, Stewart J. Levine, Steven D. Nathan
Eur Respir J, 59 (4) 2200151; 10.1183/13993003.00151-2022 | |
Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity
Sophie M. Poznanski, Ana Portillo, Manali Mukherjee, Anurag Bhalla, Kiho Son, Ali A. Ashkar, Nader Khalidi, Parameswaran Nair
Eur Respir J, 59 (4) 2102210; 10.1183/13993003.02210-2021 | |
“Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension.” Catherine E. Simpson, Jenny Y. Chen, Rachel L. Damico, et al. Eur Respir J 2020; 55: 1901761.
Eur Respir J, 59 (4) 1951761; 10.1183/13993003.51761-2019 | |
“Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.” Nikhil Hirani, Alison C. MacKinnon, Lisa Nicol, et al. Eur Respir J 2021; 57: 2002559.
Eur Respir J, 59 (4) 2052559; 10.1183/13993003.52559-2020 | |